Study
Human Milk Sugar Enhances Gut Health and Memory in Older Adults
Taking 2′-fucosyllactose, a sugar found in human milk, improved gut health and memory in older adults.
Summary
In plain language
Researchers found that 2′-fucosyllactose (2′-FL), a sugar naturally present in human breast milk, can support gut health and enhance memory in older adults. In a study involving 89 participants aged 60 and above, those who consumed 2′-FL showed an increase in beneficial gut bacteria and performed better on visual memory tests. This suggests that 2′-FL could offer benefits beyond infancy, possibly supporting healthy aging by improving gut bacteria and metabolism. While the study noted an increase in certain beneficial hormones and cholesterol levels, it did not find changes in inflammation markers. These findings highlight the potential of 2′-FL as a supplement for older adults. As always, it's important to discuss new supplements with your healthcare provider before starting them.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was a 6-week trial conducted with 89 healthy older adults, who were divided into groups receiving either a high dose, a low dose of 2′-FL, or a placebo.
Participants consuming 2′-FL showed increased levels of Bifidobacterium, a beneficial gut bacteria, and improvements in visual memory tests.
The study also recorded increases in HDL cholesterol and insulin levels, but no significant changes in inflammation markers.
While promising, the study did not observe changes in all targeted health markers, and further research is needed to explore long-term effects.
Discuss with your healthcare provider if considering 2′-FL as a supplement to support gut health and cognitive function.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Human Milk Sugar Enhances Gut Health and Memory in Older Adults
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scores highly for its rigorous RCT design and comprehensive statistical methods. Transparency is strong with pre-registration and data sharing. However, significant conflicts of interest due to industry ties reduce the conflicts score. The study's relevance to older adults and publication in a high-quality journal contribute positively to the overall score.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 6.7/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This randomized controlled trial investigates the effects of 2'-fucosyllactose on gut microbiota, metabolic markers, and cognitive function in older adults. It finds increased Bifidobacterium levels and improved visual memory in responders.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Dementia
Dementia is a broad term used to describe a decline in cognitive function that interferes with daily life. It predominantly affects older adults, with symptoms like memory loss and changes in behavior. Dementia is not a normal part of aging, and early diagnosis is crucial for management.
Inflammaging
Inflammaging is a term used to describe the chronic, low-grade inflammation that occurs as we age. This chronic inflammation can contribute to a variety of age-related diseases, including heart disease, Alzheimer's disease, and cancer. Understanding inflammaging can help us develop strategies to promote healthy aging and reduce the risk of age-related diseases.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.